it's kind of inevitable that myx will bottom out at some stage soon, the accounts show that the impairments have dropped approximately $500m in net profit over the last three years. Effectively since they overpaid for generics, these losses have also pushed the market cap from a $1.3 billion company to around $5-600 million. Once these impacts are washed out, and the accounts look cleaner (not in the red) with a few other cash generating drugs in the line then a correction to moving upwards in share price to a market cap of around 7-800mill
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.08 | $5.02 | $395.8K | 78.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $5.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.08 | 3084 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| MYX (ASX) Chart |